Scopri l’azienda
About us
INSPIRE was founded in 2020 as an academic spin-off of the University of Messina, with the aim of developing innovative solutions in eHealth, predictive medicine and healthcare data integration.
Over the years, INSPIRE has consolidated its growth and scientific expertise in the use of big data, real-world data, advanced analytics, algorithms and digital platforms to support clinical research, healthcare decision-making and the evaluation of medicines and healthcare interventions. Its activities encompass Real World Evidence, pharmacoepidemiology, pharmacovigilance, drug utilization and appropriateness, healthcare data analytics, systematic reviews and meta-analyses, as well as innovative approaches based on artificial intelligence.
In 2022, INSPIRE was accredited as an academic spin-off of the University of Verona, strengthening its collaboration with the academic and healthcare community. Today, INSPIRE brings together scientific expertise, methodological rigor and technological innovation to transform complex real-world data into reliable and actionable evidence, supporting research, healthcare governance and the sustainable improvement of healthcare services.
Our Mission
INSPIRE develops, produces and delivers innovative, high-technology products and services for medical prediction and big data integration in real-world healthcare settings.
By combining advanced analysis of healthcare databases, ad hoc data collection through web applications and robust predictive algorithms, INSPIRE supports public bodies, pharmaceutical companies and healthcare organizations in improving quality of care, clinical outcomes and the sustainability of health systems.
Quality is embedded in every project through rigorous methodology, transparent processes and alignment with international standards in pharmacoepidemiology, pharmacovigilance and real-world evidence generation.
Our Vision
INSPIRE’s vision is to build an integrated ecosystem in which clinical, regulatory and organizational decisions are consistently guided by timely, robust and accessible real-world evidence.
INSPIRE strives for a future where interoperable data infrastructures, advanced predictive algorithms and user-friendly digital tools reduce diagnostic delays, optimize therapies and enhance patient safety, especially in chronic and rare diseases.
Working within a dynamic network of universities, research consortia, regulatory agencies, healthcare institutions and technology partners, INSPIRE is committed to continuously raising the quality bar in the use of real-world healthcare data for public health improvement.
Prof. Ylenia Ingrasciotta
Associate Professor of Pharmacology at the Department of Diagnostics and Public Health, University of Verona
Chief Executive Officer (CEO)
Born in ‘86, she graduated in Pharmacy (Chemistry and Pharmaceutical Technology). She is licensed to practice as a pharmacist, and she is a specialist in Medical Clinical Pharmacology. She earned a PhD in Pharmacoepidemiology at the Erasmus Medical Center in Rotterdam (The Netherlands) and a Second-Level Master’s Degree in Pharmacovigilance, Pharmacoepidemiology and Pharmacoeconomics: Evaluations through the Use of Real-World Data from the University of Messina. Since 2024, she has been a member of the Executive Committee of the Clinical Pharmacology Section of the Italian Society of Pharmacology (SIF).
Since 2026, she has been an Associate Professor of Pharmacology at the University of Verona. She is the author of more than 70 publications in national and international peer-reviewed indexed scientific journals, as well as several book chapters in pharmacology, and has received five research awards from scientific societies.
Her main research areas include:
- Pharmacoepidemiology and Real-World Evidence (RWE): coordination and participation in national and international research projects based on real-world data (RWD) for the post-marketing evaluation of medicinal products, with a particular focus on originator biologics and biosimilars.
- Active pharmacovigilance and drug safety.
- Appropriate prescribing and optimization of chronic therapies, particularly for patients with type 2 diabetes mellitus and chronic inflammatory diseases.
- Innovative methodologies for healthcare big data analysis and the development of digital health tools.
In addition to her executive and administrative responsibilities, she also serves as Project Manager for INSPIRE’s scientific activities, coordinating and overseeing the company’s research projects.
Prof. Gianluca Trifirò
Full Professor of Pharmacology at the Department of Diagnostics and Public Health, University of Verona
Scientific Director and Chairman of the Board of Directors (CBD)
Born in 1978, he is a Full Professor of Pharmacology, physician, and specialist in Clinical Pharmacology. He earned a PhD in Pharmacoepidemiology at the Erasmus Medical Center in Rotterdam (The Netherlands), where he worked as an Assistant Professor in the Department of Medical Informatics until 2011.
He is a member of the Steering Group of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) of the European Medicines Agency (EMA), a member of the Advisory Board of the International Society of Pharmacovigilance (ISoP), and serves on the Executive Committee of the Clinical Pharmacology Section of the Italian Society of Pharmacology (SIF).
He has coordinated numerous national and international research projects based on healthcare databases and real-world data. He is the author of more than 180 articles published in international peer-reviewed scientific journals.
He is also the editor of the book Real World Evidence e Farmaci: applicazioni e criticità nel contesto Italiano (Real-World Evidence and Medicines: Applications and Challenges in the Italian Context), published by SEEd Editore.
Prof. Angela Alibrandi
Associate Professor of Medical Statistics (MED-01) at the Department of Economics, Division of Statistical and Mathematical Sciences, University of Messina
Born in ‘78, she graduated in Statistical, Demographic and Social Sciences. She served as a Research Fellow (Assistant Professor equivalent) at the University of Messina from 2006 to 2019 and obtained the Italian National Scientific Qualification (Abilitazione Scientifica Nazionale) in 2017.
Since the 31st of December 2019, she has been an Associate Professor in the field of Biostatistics. She is the author of more than 240 publications in international peer-reviewed indexed scientific journals.
Prof. Claudio Guarneri
Full Professor of Dermatology and Venereology at the BIOMORF Department, University of Messina
Born in ‘73, after graduating in Medicine and Surgery and completing his specialization in Dermatology and Venereology at the University of Messina, he served as a First-Level Medical Director at the Complex Dermatology Unit of the “Pugliese–Ciaccio” Regional Hospital in Catanzaro from 2005 to 2006.
Since 2006, he has held academic positions at the University of Messina, first as an Assistant Professor and Researcher, and subsequently as Full Professor of Dermatology and Venereology. He is the author of more than 170 publications in international peer-reviewed indexed scientific journals, as well as book chapters and monographs.
His main research interests include:
- Pathogenesis and clinical manifestations of psoriasis, including associated comorbidities and biologic therapies.
- Cutaneous adverse drug reactions and pharmacovigilance.
- Diagnosis and treatment of cutaneous melanoma.
- Infectious skin diseases.
Ieeng Solution
Founded in 2010, Ieeng Solution is an Italian software house specialized in custom software development, IT consulting, and digital transformation. The company designs and develops scalable web platforms, mobile applications, business management systems, e-commerce solutions, and cloud-based software tailored to the needs of private companies, public administrations, and healthcare organizations.
Over the years, Ieeng Solution has contributed to several national research and innovation initiatives, collaborating with universities, research centers, and industrial partners to develop advanced digital solutions. Among its most significant projects is AEROMAT, an initiative focused on the adoption of innovative technologies, advanced materials, and digital models for the aeronautics sector. The company has also played a key role in RehaStart, a project dedicated to the development of digital solutions supporting rehabilitation and healthcare services, and VESPA 2.0, an innovation project aimed at enhancing public services through advanced digital technologies and integrated software platforms.
Alongside bespoke software development, the company has created proprietary solutions such as Task2Me, a modular business management platform designed to simplify business operations and improve organizational efficiency.
Ieeng Solution combines engineering expertise with a customer-focused approach, supporting every stage of a project—from business analysis and software design to development, deployment, and ongoing maintenance. The company’s commitment to quality and information security is demonstrated by its ISO 9001:2015 and ISO/IEC 27001:2022 certifications, ensuring reliable, secure, and high-quality digital solutions.
